105 assets in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

f520

Lenvatinib

Linperlisib

L-Methionyl-Interleukin 15 (Human, Non-Glycosylated), Produced In Escherichia Coli, Substituted On An Average Of One Site Among N2 Of Met1 And/Or N6 Of Lysyl Residues With 4-(.Alpha.-Methylpoly(Oxyethylene)-.Omega.-Oxy)Butanoyl Groups (~40 Kda Each)

Mitoxantrone

Ontorpacept

Pirtobrutinib

Plerixafor

Poseltinib

Vinorelbine Ditartrate

Zamtocabtagene Autoleucel

Zirconium Zr 89 Crefmirlimab Berdoxam

Ociperlimab

Tislelizumab

Anti-Cd20/Cd3 Monoclonal Antibody Regn1979

Clofarabine

Tazemetostat

Tocilizumab

Adenosine, N-Cyclopentyl-

Atg-010

Copanlisib

crc01

Duvelisib

Lisaftoclax

tc011

Mosunetuzumab

Prizloncabtagene Autoleucel

1-118-Signal regulatory protein ? (human) fusion protein with immunoglobulin G4 [128-proline] (human ?4-chain C region C-terminal fragment), dimer

Immunoglobulin G1, Anti-(Human Cd Antigen Cd27) (Human Monoclonal Cdx-1127 Clone 1F5 Heavy Chain), Disulfide With Human Monoclonal Cdx-1127 Clone 1F5 .Kappa.-Chain, Dimer

Bgb-21447

Efineptakin Alfa

ezm0414

Gf-Cart01

Interleukin 18 (Recombinant Human Mutein Clone St-067)

Kite-197

Mdc-Car-Bcma001

Vancomycin

VK2019

Anti-Cd19-Car Cmv-Specific T-Lymphocytes

Autologous Baffr-Targeting Car T Cells

Autologous Cd19Car-Cd28-Cd3Zeta-Egfrt-Expressing Tcm-Enriched T Cells

Autologous Cd19Car-Cd28-Cd3Zeta-Egfrt-Expressing Tn/Mem-Enriched T-Lymphocytes

Carfilzomib

Cedazuridine

Egfrt/19-28Z/Il-12 Car T-Lymphocytes

fkc876

Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine

Onatasertib

Pevonedistat

rc19d2 cell